Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy | MicrobiomeTrials← Back to trialsNCT05756660
Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
SUSPENDEDEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2023-03-01Est. Completion: 2027-01
Enrollment target: 33 participants Locations- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Other microbiome trials you might be interested in
CancerOtotoxicity, Drug-InducedQuality of LifeHearing Disorders
There are many undesirable effects associated with platinum-based cancer treatments (renal failure, anaemia, etc.). Thei…
Vandœuvre-lès-Nancy, FranceEst. completion Jun 5, 2027
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing LossCisplatin OtotoxicityHead and Neck CancerDizzynessInner Ear Hearing Loss
Vestibular Disease
Squamous Cell Carcinoma of the Head and Neck
Deafness
Hearing Loss
The goal of this observational study is to learn about the occurrence of and to identify suitable strategies for screeni…
Nuremberg, GermanyEst. completion Jun 2027